JPRN-jRCT2031230033招募中1 期
A Phase 1 study of S-337395 in healthy adult participants
Gomez Juan Carlos0 个研究点目标入组 83 人开始时间: 2023年4月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 83
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 55age old（—）
- 性别
- All
入选标准
- •Those who aged >=18 to =<55 years, at the time of signing the informed consent form.
- •- Those who have body mass index of >=18.5 (kg/m2) to =<30.0 (kg/m2).
排除标准
- •Considered by the investigator or subinvestigator (suitably qualified) to be ineligible for the study due to a history of or current condition of significant metabolic or endocrine, hepatic, renal, hematological, cardiovascular, gastrointestinal or neurological disorders that are considered by the investigator to constitute a safety risk upon the study drug administration or to interfere with the interpretation of data.
研究者
相似试验
已完成
1 期
Phase 1 study of EA3571 in healthy adult subjectsonalcoholic SteatohepatitisJPRN-jRCT2051220036Takeuchi Yutaka163
已完成
1 期
A Phase 1 study of S-217622COVID-19JPRN-jRCT2031210202agata Tsutae201
已完成
不适用
A phase I clinical pharmacology study of SJP-0135Healthy adultsJPRN-UMIN000029001Senju Pharmaceutical Co.,Ltd.30
已完成
不适用
A phase I clinical pharmacology study of SJP-0139 with a single-dose and multiple-dose administration in healthy male volunteersJapanese healthy adult male volunteersJPRN-UMIN000030621Senju Pharmaceutical Co.,Ltd.12
招募中
1 期
A Phase 1 Study of S-892216 (COVID-19)COVID-19JPRN-jRCT2031230082Gomez Juan Carlos248